TD Private Client Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.38M Buy
5,854
+287
+5% +$291K 0.11% 124
2025
Q4
$5.98M Sell
5,567
-331
-6% -$316K 0.13% 106
2025
Q3
$4.5M Sell
5,898
-24
-0.4% -$17.9K 0.1% 140
2025
Q2
$4.62M Buy
5,922
+315
+6% +$245K 0.11% 134
2025
Q1
$4.63M Buy
5,607
+169
+3% +$141K 0.13% 117
2024
Q4
$4.2M Sell
5,438
-7,105
-57% -$5.88M 0.12% 129
2024
Q3
$11.1M Buy
12,543
+669
+6% +$601K 0.32% 57
2024
Q2
$10.8M Sell
11,874
-4,870
-29% -$3.9M 0.34% 52
2024
Q1
$13M Buy
16,744
+1,096
+7% +$780K 0.43% 46
2023
Q4
$9.12M Sell
15,648
-1,243
-7% -$726K 0.33% 56
2023
Q3
$9.07M Sell
16,891
-936
-5% -$482K 0.39% 43
2023
Q2
$8.36M Buy
17,827
+4,828
+37% +$2.02M 0.36% 51
2023
Q1
$4.46M Buy
12,999
+25
+0.2% +$8.43K 0.2% 113
2022
Q4
$4.75M Buy
12,974
+1,259
+11% +$446K 0.22% 102
2022
Q3
$3.79M Sell
11,715
-1,848
-14% -$586K 0.19% 117
2022
Q2
$4.4M Sell
13,563
-349
-3% -$105K 0.21% 111
2022
Q1
$3.98M Sell
13,912
-885
-6% -$228K 0.17% 131
2021
Q4
$4.09M Buy
14,797
+9,876
+201% +$2.5M 0.17% 138
2021
Q3
$1.14M Sell
4,921
-158
-3% -$39K 0.05% 314
2021
Q2
$1.17M Sell
5,079
-221
-4% -$44.4K 0.05% 315
2021
Q1
$990K Sell
5,300
-183
-3% -$35.8K 0.05% 315
2020
Q4
$926K Sell
5,483
-15,364
-74% -$2.29M 0.05% 308
2020
Q3
$3.09M Sell
20,847
-817
-4% -$126K 0.17% 128
2020
Q2
$3.56M Buy
21,664
+3,174
+17% +$487K 0.21% 105
2020
Q1
$2.56M Buy
18,490
+1,773
+11% +$244K 0.18% 117
2019
Q4
$2.2M Buy
+16,717
New +$1.94M 0.13% 168

Other funds holding LLY

TD Private Client Wealth's LLY Position: Q1 2026 in Review

TD Private Client Wealth increased its Eli Lilly (LLY) stake by 5.2% in Q1 2026, buying an estimated $291K and bringing the position to 5,854 shares worth $5.38M. The position accounts for 0.11% of the portfolio, ranked #124.

TD Private Client Wealth first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $13M in Q1 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • TD Private Client Wealth held 5,854 shares of Eli Lilly worth $5.38M as of Q1 2026.
  • TD Private Client Wealth bought 287 Eli Lilly shares in Q1 2026, an estimated $291K.
  • Eli Lilly made up 0.11% of TD Private Client Wealth's portfolio in Q1 2026, its #124 holding.
  • TD Private Client Wealth first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • TD Private Client Wealth's Eli Lilly position peaked at $13M in Q1 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.